BioCentury
ARTICLE | Company News

pSivida Ltd., Auritec deal

January 15, 2007 8:00 AM UTC

Auritec's IP holding company, Faber Research LLC, received exclusive rights to use PSD's Durasert, Zanisert and Co-Drug delivery technologies to develop and commercialize treatments for malaria, HIV/A...